Literature DB >> 5088222

Activation of cyclophosphamide in man and animals.

N Brock, R Gross, H J Hohorst, H O Klein, B Schneider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5088222     DOI： 10.1002/1097-0142(197106)27:6<1512::aid-cncr2820270636>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  23 in total

1.  A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients.

Authors:  M Hassan; U S Svensson; P Ljungman; B Björkstrand; H Olsson; M Bielenstein; M Abdel-Rehim; C Nilsson; M Johansson; M O Karlsson
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

2.  The mammalian spot test (Fellfleckentest) with mice.

Authors:  R Fahrig
Journal:  Arch Toxicol       Date:  1977-09-21       Impact factor: 5.153

Review 3.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  L B Grochow; M Colvin
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

4.  Mutation and recombination experiments with yeast as prescreening tests for carcinogenic effects?

Authors:  H Marquardt
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

5.  The effect of microsomal enzyme inhibition on the immunosuppressive and toxic effects of cyclophosphamide.

Authors:  M C Berenbaum; W A Cope; J A Double
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

6.  Effects of 3,3',4,4'-tetrachloroazoxybenzene on selected immune parameters of the mouse.

Authors:  M R Bleavins; R D Hinsdill; J R Hochstein; M T Hsia
Journal:  Arch Environ Contam Toxicol       Date:  1985-11       Impact factor: 2.804

7.  Transplacental mutagenesis: the micronucleus test on fetal mouse blood.

Authors:  M T King; D Wild
Journal:  Hum Genet       Date:  1979-10-01       Impact factor: 4.132

8.  Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration.

Authors:  F D Juma; H J Rogers; J R Trounce
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

9.  [The effect of cyclophosphamide on tumors in the sensitivity-test (author's transl)].

Authors:  M Kaufmann; J Mattern; K Wayss; M Volm
Journal:  Arch Gynakol       Date:  1975

10.  The disposition of cyclophosphamide in a group of myeloma patients.

Authors:  V Bramwell; R T Calvert; G Edwards; H Scarffe; D Crowther
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.